Inventive Clinical Solutions is categorized under Wholesale Pharmaceutical Products in Malvern, PA .
Inventive Clinical Solutions was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Larry Fondren at the company’s single location by writing to 5 Great Valley Parkway # 359, Malvern, Pennsylvania PA 19355 or by phoning (903) 849-6994. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Inventive Clinical Solutions |
| Contact Person: | Larry Fondren |
| Address: | 5 Great Valley Parkway # 359, Malvern, Pennsylvania 19355 |
| Phone Number: | (903) 849-6994 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Inventive Clinical Solutions was started in 0 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Larry Fondren for inquiries that concern Inventive Clinical Solutions by calling the company number (903) 849-6994, as your correspondence is most welcome. Additionally, the physical location of the single location of Inventive Clinical Solutions can be found at the coordinates as well as the street address 5 Great Valley Parkway # 359 in Malvern, Pennsylvania 19355.
For its online presence, you may visit Inventive Clinical Solutions’s website at and engage with its social media outlets through on Twitter and on Facebook.